4//SEC Filing
CoLucid Pharmaceuticals, Inc. 4
Accession 0000911916-15-000306
CIK 0001348649operating
Filed
Aug 5, 8:00 PM ET
Accepted
Aug 6, 2:00 PM ET
Size
5.4 KB
Accession
0000911916-15-000306
Insider Transaction Report
Form 4
Dallas Matthew D
Chief Financial Officer
Transactions
- Award
Employee Stock Option (Right to Buy)
2015-08-04+30,000→ 30,000 totalExercise: $7.56Exp: 2025-08-04→ Common Stock (30,000 underlying)
Footnotes (1)
- [F1]Options vest as to one-fourth of the shares on August 4, 2016 and as to the remaining shares in a series of 36 successive equal monthly installments upon completion of each additional month of service.
Documents
Issuer
CoLucid Pharmaceuticals, Inc.
CIK 0001348649
Entity typeoperating
Related Parties
1- filerCIK 0001348649
Filing Metadata
- Form type
- 4
- Filed
- Aug 5, 8:00 PM ET
- Accepted
- Aug 6, 2:00 PM ET
- Size
- 5.4 KB